EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C15H11ClN2O2 |
| Net Charge | 0 |
| Average Mass | 286.718 |
| Monoisotopic Mass | 286.05091 |
| SMILES | O=C1CC(=O)N(c2ccccc2)c2cc(Cl)ccc2N1 |
| InChI | InChI=1S/C15H11ClN2O2/c16-10-6-7-12-13(8-10)18(11-4-2-1-3-5-11)15(20)9-14(19)17-12/h1-8H,9H2,(H,17,19) |
| InChIKey | RRTVVRIFVKKTJK-UHFFFAOYSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Rattus norvegicus (ncbitaxon:10116) | liver (BTO:0000759) | MetaboLights (MTBLS4163) |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| N-Desmethylclobazam (CHEBI:190616) is a benzodiazepine (CHEBI:22720) |
| IUPAC Name |
|---|
| 7-chloro-5-phenyl-1H-1,5-benzodiazepine-2,4-dione |
| Manual Xrefs | Databases |
|---|---|
| 80921 | ChemSpider |
| HMDB0060970 | HMDB |
| Registry Numbers | Sources |
|---|---|
| CAS:22316-55-8 | ChemIDplus |